Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Teitelbaum Law Group
- Blitman & King
- Bielli & Klauder
- Tarter Krinsky
- Simmons Hanly
- Stevens & Lee
- Godfrey & Kahn
- Pillsbury Winthrop
- Gilbert LLP
- Davis Polk
- Himes Petrarca
- BatesCarey
- Lowe Stein
- McDermott Will & Schulte
- Wachtell Lipton
- Porter Hedges
- Gage Spencer & Fleming
- Consovoy McCarthy
- Gertz & Rosen
- Porteous Hainkel
- Andrews & Thornton
- Skadden Arps
- ASK LLP
- Joseph Hage
- Spangenberg Shibley
- Cuneo Gilbert
- Motley Rice
- WestLoop Law
- Cronin Fried
- Slevin & Hart
- Doshi Legal Group
- Bentley & Bruning
- Pachulski Stang
- Lerner Arnold
- Kramer Levin
- Brown Rudnick
- Bialson Bergen
- White & Case
- Martin S. Rapaport
- Kirkland & Ellis
- Marino Tortorella
- Potter Anderson
- Faegre Drinker
- Morgan Lewis
- Saul Ewing
- Burke Warren
- Debevoise & Plimpton
- Arnold & Porter
- King & Spalding
- Goodwin Procter
- Wilk Auslander
- Stutzman Bromberg
- Mintz Levin
- McGrail & Bensinger
- ArentFox Schiff
- WilmerHale
- Jones Day
- Brown & Connery
- Hagens Berman
- Miller Nash LLP
- Kobre & Kim
- Foley & Lardner
- Porzio Bromberg
- Napoli Shkolnik
- Robins Kaplan
- Marcus & Shapira
- Dentons
- Willkie Farr
- Shook Hardy
- Crowell & Moring
- Shafferman & Feldman
- Ballard Spahr
- Hughes Socol
- Reed Smith
- Pashman Stein
- Keller Rohrback
- Duane Morris
- O'Melveny & Myers
- UB Greensfelder
- Seyfarth Shaw
- Taft Stettinius
- Troutman
- Kleinberg Kaplan
- Katsky Korins
- Clifford Law Offices
- Barack Ferrazzano
- Terrell Hogan
- Sherrard Roe
- Levenfeld Pearlstein
- Rothstein Mandell
- Phillips Lytle
- Doster Ullom
- Cleary Gottlieb
- MacElree Harvey
- Loeb & Loeb
- Blank Rome
- Hurwitz Fine
- Keller Postman
- Pullman & Comley
- Mehri & Skalet
- MoloLamken
- Tate Law Group LLC
- Klehr Harrison
- Frost Brown
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Dechert LLP
- Quinn Emanuel
- Ifrah Law
- Seward & Kissel
- Simpson Thacher & Bartlett LLP
- Lite DePalma
- Squire Patton
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
Companies
- Teamsters Local 456
- Johnson & Johnson
- Henry Schein Inc.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Otis Worldwide Corp.
- Impax Laboratories, Inc.
- Kodiak Area Native Association
- Ranbaxy
- Tucson Medical Center
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Omnicare Inc.
- Endo International PLC
- Giant Eagle Inc.
- Bausch Health Cos. Inc.
- Province LLC
- United Parcel Service Inc.
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- McKesson Corp.
- Cencora Inc.
- Express Scripts Holding Co.
- Hain Capital Group LLC
- Walmart Inc.
- KVK Tech Inc.
- Amneal Pharmaceuticals Inc.
- Loblaw Cos.
- TR Capital Management LLC
- The Cigna Group
- Ironshore Inc.
- Noramco Inc.
- Alaska Native Tribal Health Consortium
- Anda Inc.
- AlixPartners LLP
- AXA XL Ltd.
- Allergan PLC
- Purdue Pharma LP
- CVS Health Corp.
- United Food & Commercial Workers International Union
- Viatris Inc.
- FTI Consulting Inc.
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- DuPont de Nemours Inc.
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Seldovia Village Tribe
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- Pala Band of Mission Indians
- U.S. District Court for the District of Columbia
- Town of Ramapo, New York
- City of Bayonne, New Jersey
- Commonwealth of Massachusetts
- State of Nevada
- Washington State Department of Revenue
- Nez Perce Tribe
- Port Gamble S'Klallam Tribe
- Borough of Paramus, New Jersey
- Jamestown S'Klallam Tribe
- Northwestern Band of the Shoshone Nation
- St. Regis Mohawk Tribe
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Hopi Tribe
- State of Indiana
- Tennessee Attorney General's Office
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
May 26, 2021
Purdue Statement Gives Creditors Enough Info, Judge Says
A New York bankruptcy judge gave a preliminary nod Wednesday to Purdue Pharma's Chapter 11 plan disclosures, but held off on an approval order after the drugmaker said it needed to clear up some disputes and add a few details to the statement.
-
May 24, 2021
Purdue's New Ch. 11 Plan Docs Detail Claims Trust Framework
Bankrupt drug manufacturer Purdue Pharma LP filed an amended Chapter 11 plan and supporting documents Monday in New York court that provide details on how $1.4 billion in distributions will be shared by different groups of claimants in the case.
-
May 20, 2021
Purdue Says It May Have To Push Back Ch. 11 Schedule
Drugmaker Purdue Pharma told a New York bankruptcy judge Thursday that it may not be able to keep to the schedule it set for its Chapter 11 case, saying it is hitting some "intractable" issues as it negotiates the terms of its restructuring.
-
May 12, 2021
Purdue's Ch. 11 Confirmation Hearing Set For August
A New York bankruptcy judge on Wednesday approved a motion setting an August date for Purdue Pharma's Chapter 11 plan confirmation hearing, assuming the drugmaker's plan disclosure statement is approved next week.
-
May 07, 2021
Purdue Asks For Another Month's Hold On Opioid Suits
Purdue Pharma is asking a New York bankruptcy judge for another 27-day extension of an injunction freezing opioid suits against the company and its owners, saying it needs more time to ensure it gets court approval for its Chapter 11 plan disclosures.
-
April 27, 2021
Newborn Opioid Victim Group Says Purdue Docs Lack Info
A group representing the interests of victims of neonatal abstinence syndrome in the bankruptcy case of opioid maker Purdue Pharma told a New York judge late Monday that the debtor's Chapter 11 plan documents don't provide enough information about their treatment.
-
April 08, 2021
Purdue Wants Another Month's Reprieve From Opioid Suits
Purdue Pharma has asked a New York bankruptcy judge for another month of relief from lawsuits over its opioid sales, saying negotiations on the final form of its Chapter 11 plan are at a "critical stage."
-
April 06, 2021
Purdue Judge Wary Of Changing Reasons For Ch. 11 Probe
A New York bankruptcy judge has asked a committee representing children allegedly injured by Purdue Pharma-made opioids to clarify why they are seeking a probe into OxyContin toxicology studies, saying its reasons have shifted since they first asked.
-
March 24, 2021
Purdue, Sackler Opioid Suits Paused For Another Month
A New York bankruptcy judge on Wednesday granted Purdue Pharma and its former owners another month's relief from suits over Purdue's opioid sales, saying the continued pause will protect efforts to work out the details of the company's Chapter 11 plan.
-
March 22, 2021
States Say Time Has Come To Let Sackler Suits Proceed
A group of states asked a New York bankruptcy judge Friday to deny Purdue Pharma's latest request to extend the injunction pausing their suits against the Sackler family, saying allowing their claims to go forward will create a better Chapter 11 plan.